Altered expression of nerve growth factor and its receptors in the kidneys of diabetic rats

Journal of Nephrology

Volumn 24, Issue 6, 2011, Pages 798-805

  Aloe, Luigi ^a   Rossi, Simona ^a   Manni, Luigi ^a  

^a CNR   (Italy)

Author keywords

Diabetes; Growth factors; Kidney; Nerve growth factor

Indexed keywords

NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY; KIDNEY DISEASE; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; RAT; STRUCTURE ANALYSIS; TISSUE LEVEL; TISSUE STRUCTURE; UPREGULATION;

ANIMALS; CELL SURVIVAL; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; DOWN-REGULATION; INJECTIONS; KIDNEY; MALE; NERVE GROWTH FACTOR; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, NERVE GROWTH FACTOR; STREPTOZOCIN; UP-REGULATION;

EID: 80955132213     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/JN.2011.6418     Document Type: Article

References (40)

1. Adeghate E. Distribution of calcitonin-gene-related peptide, neuropeptide-Y, vasoactive intestinal polypeptide, cholecystokinin-8, substance P and islet peptides in the pancreas of normal and diabetic rats. Neuropeptides. 1999;33:227-235.
2. Marchant K. Diabetes and chronic kidney disease: a complex combination. Br J Nurs. 2008;17:356-361.
3. Sariola H, Saarma M, Sainio K, et al. Dependence of kidney morphogenesis on the expression of nerve growth factor receptor. Science. 1991;254:571-573.
4. Vidaltamayo R, Sanchez-Soto MC, Hiriart M. Nerve growth factor increases sodium channel expression in pancreatic beta cells: implications for insulin secretion. FASEB J. 2002;16:891-892.
5. Caramori ML, Mauer M. Diabetes and nephropathy. Curr Opin Nephrol Hypertens. 2003;12:273-282.
6. Alpers CE, Hudkins KL, Ferguson M, Johnson RJ, Schatteman GC, Bothwell M. Nerve growth factor receptor expression in fetal, mature, and diseased human kidneys. Lab Invest. 1993;69:703-713.
7. Azar ST, Major SC, Safieh-Garabedian B. Altered plasma levels of nerve growth factor and transforming growth factor-beta2 in type-1 diabetes mellitus. Brain Behav Immun. 1999;13:361-366.
8. Faradji V, Sotelo J. Low serum levels of nerve growth factor in diabetic neuropathy. Acta Neurol Scand. 1990;81:402-406.
9. Huber LJ, Hempstead B, Donovan MJ. Neurotrophin and neurotrophin receptors in human fetal kidney. Dev Biol. 1996;179:369-381.
10. Heese K, Beck KF, Behrens MH, et al. Effects of high glucose on cytokine-induced nerve growth factor (NGF) expression in rat renal mesangial cells. Biochem Pharmacol. 2003;65:293-301.
11. Apfel SC, Arezzo JC, Brownlee M, Federoff H, Kessler JA. Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res. 1994;634:7-12.
12. Connor B, Dragunow M. The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res Brain Res Rev. 1998;27:1-39.
13. Levi-Montalcini R. The nerve growth factor: thirty-five years later. Science. 1987;237:1154-1162.
14. Raile K, Klammt J, Garten A, et al. Glucose regulates expression of the nerve growth factor (NGF) receptors TrkA and p75NTR in rat islets and INS-1E beta-cells. Regul Pept. 2006;135:30-38.
15. Reimer MK, Mokshagundam SP, Wyler K, Sundler F, Ahren B, Stagner JI. Local growth factors are beneficial for the autonomic reinnervation of transplanted islets in rats. Pancreas. 2003;26:392-397.
16. Vidaltamayo R, Mery CM, Angeles-Angeles A, Robles-Diaz G, Hiriart M. Expression of nerve growth factor in human pancreatic beta cells. Growth Factors. 2003;21:103-107.
17. Aloe L and Calzà L (editors). NGF and related molecules in health and disease. Prog Brain Res 2004; 146. Elsevier B.V.
18. Casaccia-Bonnefil P, Gu C, Chao MV. Neurotrophins in cell survival/death decisions. Adv Exp Med Biol. 1999;468:275-282.
19. Meakin SO, Shooter EM. The nerve growth factor family of receptors. Trends Neurosci. 1992;15:323-331.
20. Rosenbaum T, Vidaltamayo R, Sanchez-Soto MC, Zentella A, Hiriart M. Pancreatic beta cells synthesize and secrete nerve growth factor. Proc Natl Acad Sci U S A. 1998;95:7784-7788.
21. Generini S, Tuveri MA, Matucci Cerinic M, Mastinu F, Manni L, Aloe L. Topical application of nerve growth factor in human diabetic foot ulcers. A study of three cases. Exp Clin Endocrinol Diabetes. 2004;112:542-544.
22. Salis MB, Graiani G, Desortes E, Caldwell RB, Madeddu P, Emanueli C. Nerve growth factor supplementation reverses the impairment, induced by Type 1 diabetes, of hind limb postischaemic recovery in mice. Diabetologia. 2004;47:1055-1063.
23. Bonofiglio R, Antonucci MT, Papalia T, et al. Nerve growth factor (NGF) and NGF-receptor expression in diseased human kidneys. J Nephrol. 2007;20:186-195.
24. Antonucci MT, Bonofiglio R, Papalia T, et al. Nerve growth factor and its monocyte receptors are affected in kidney disease. Nephron. 2009;111:c21-c28.
25. Sanchez-Nino MD, Sanz AB, Lorz C, et al. BASP1 promotes apoptosis in diabetic nephropathy. J Am Soc Nephrol. 2010;21:610-621.
26. Ortiz A, Ziyadeh FN, Neilson EG. Expression of apoptosisregulatory genes in renal proximal tubular epithelial cells exposed to high ambient glucose and in diabetic kidneys. J Investig Med. 1997;45:50-56.
27. Sato Y, Feng GG, Huang L, et al. Enhanced expression of naofen in kidney of streptozotocin-induced diabetic rats: possible correlation to apoptosis of tubular epithelial cells. Clin Exp Nephrol. 2010;14:205-212.
28. Sanchez-Nino MD, Sanz AB, Ortiz A. Caspase-12 and diabetic nephropathy: from mice to men? J Am Soc Nephrol. 2010;21:886-888.
29. Hammes HP, Federoff HJ, Brownlee M. Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes. Mol Med. 1995;1:527-534.
30. Larrieta ME, Vital P, Mendoza-Rodriguez A, Cerbon M, Hiriart M. Nerve growth factor increases in pancreatic beta cells after streptozotocin-induced damage in rats. Exp Biol Med (Maywood). 2006;231:396-402.
31. Bocchini V, Angeletti PU. The nerve growth factor: purification as a 30,000-molecular-weight protein. Proc Natl Acad Sci U S A. 1969;64:787-794.
32. Vigneti E, Bracci-Laudiero L, Aloe L. Production and characterization of a monoclonal antibody against nerve growth factor (NGF) which recognizes rodent and human NGF. Year Immunol. 1993;7:146-149.
33. Taniuchi M, Schweitzer JB, Johnson EM Jr. Nerve growth factor receptor molecules in rat brain. Proc Natl Acad Sci U S A. 1986;83:1950-1954.
34. Aloe L, Tirassa P, Alleva E. Cold water swimming stress alters NGF and low-affinity NGF receptor distribution in developing rat brain. Brain Res Bull. 1994;33:173-178.
35. Coassin M, Lambiase A, Sposato V, Micera A, Bonini S, Aloe L. Retinal p75 and BAX overexpression is associated with retinal ganglion cells apoptosis in a rat model of glaucoma. Graefes Arch Clin Exp Ophthalmol. 2008; 246(12):1743-9.
36. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119:493-501.
37. Lambiase A, Rama P, Bonini S, Caprioglio G, Aloe L. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Engl J Med. 1998;338:1174-1180.
38. Lambiase A, Centofanti M, Micera A, et al. Nerve growth factor (NGF) reduces and NGF antibody exacerbates retinal damage induced in rabbit by experimental ocular hypertension. Graefes Arch Clin Exp Ophthalmol. 1997;235:780-785.
39. Lambiase A, Bonini S, Aloe L, Rama P, Bonini S. Anti-inflammatory and healing properties of nerve growth factor in immune corneal ulcers with stromal melting. Arch Ophthalmol. 2000;118:1446-1449.
40. Reinshagen M, Rohm H, Steinkamp M, et al. Protective role of neurotrophins in experimental inflammation of the rat gut. Gastroenterology. 2000;119:368-376.